摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-双(三氟甲氧基)苯甲醇 | 1121586-22-8

中文名称
3,5-双(三氟甲氧基)苯甲醇
中文别名
(3,5-双(三氟甲氧基)苯基)甲醇
英文名称
(3,5-Bis(trifluoromethoxy)phenyl)methanol
英文别名
[3,5-bis(trifluoromethoxy)phenyl]methanol
3,5-双(三氟甲氧基)苯甲醇化学式
CAS
1121586-22-8
化学式
C9H6F6O3
mdl
——
分子量
276.13
InChiKey
QYGQPWWIBDHPFX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    221℃
  • 密度:
    1.500
  • 闪点:
    110℃

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    9

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

文献信息

  • [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2005042542A1
    公开(公告)日:2005-05-12
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.
    本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物:(1)在上述式(1)中,R1代表氢原子或C1-C6烷基,n代表0至6的整数,R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环,与相邻的碳原子一起(在下面的式中,RRR代表可能在哌啶环上具有取代基的哌啶基),(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
  • 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles
    申请人:Tsubouchi Hidetsugu
    公开号:US20060094767A1
    公开(公告)日:2006-05-04
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R 1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R 2 represents a group —OR 3 or the like, and R 3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R 1 and —(CH 2 ) n R 2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R 41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.
    本发明提供了一种2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物,其通式如下:其中,R1代表氢原子或C1-C6烷基,n代表0到6的整数,R2代表—OR3或类似的基团,R3代表氢原子、C1-C6烷基或类似的基团,或者R1和—(CH2)nR2可以通过相邻的碳原子通过氮原子结合在一起形成一个螺环,其通式为(H):其中,R41为氢、C1-C6烷基或类似的基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速细菌具有优异的杀菌作用。
  • 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis
    申请人:Tsubouchi Hidetsugu
    公开号:US20080119478A1
    公开(公告)日:2008-05-22
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1) in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and —(CH2) n R2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30) and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.
    本发明提供了一种由下述通式(1)表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物: 在上述式(1)中,R1代表氢原子或C1-C6烷基,n代表0到6的整数,R1和—(CH2)nR2可以与相邻的碳原子形成如下式(30)所示的螺环,其中,在下式中,RRR代表可能在哌啶环上具有取代基的哌啶基: (30)且R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似基团。该化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型酸杆菌具有优异的杀菌作用。
  • 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP1555267A1
    公开(公告)日:2005-07-20
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and a typical acid-fast bacteria.
    本发明提供了由以下通式代表的 2,3-二氢-6-硝基咪唑并[2,1-b]恶唑化合物: 其中R1代表氢原子或C1-C6烷基,n代表0至6的整数,R2代表基团-OR3或类似基团,R3代表氢原子、C1-C6烷基或类似基团,或者R1和-(CH2)nR2可以通过氮原子与相邻的碳原子相互结合,从而形成通式(H)代表的螺环: 其中 R41 为氢、C1-C6 烷基或类似基团。本化合物对结核分枝杆菌、多重耐药结核分枝杆菌和典型的耐酸细菌有很好的杀菌作用。
  • 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP2570418A2
    公开(公告)日:2013-03-20
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.
    本发明提供了一种由以下通式表示的 2,3-二氢-6-硝基咪唑并[2,1-b]恶唑化合物: 其中R1代表氢原子或C1-C6烷基,n代表0至6的整数,R2代表基团-OR3或类似基团,R3代表氢原子、C1-C6烷基或类似基团,或者R1和-(CH2)nR2可以通过氮原子与相邻的碳原子相互结合,从而形成通式(H)代表的螺环: 其中 R41 为氢、C1-C6 烷基或类似基团。本化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型耐酸菌有很好的杀菌作用。
查看更多